InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Mineralys Therapeutics, Inc.

MLYS Clue Score35
United States Fiscal year ends December CIK 0001933414 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

14
Insider
Date
Role
Action
Shares
Price
Amount
Jon Congleton
30 Sep 2026
Chief Executive Officer
Sold on a plan
75,000
$25.46
$1.91M
David Malcom Rodman
15 Jul 2026
Chief Medical Officer
Sold on a plan
6,349
$26.61
$168.95K
Jon Congleton
13 Jul 2026
Chief Executive Officer
Sold on a plan
10,700
$27.24
$291.44K
Jon Congleton
30 Jun 2026
Chief Executive Officer
Sold on a plan
17,000
$26.82
$455.90K
Jon Congleton
30 Jun 2026
Chief Executive Officer
Sold on a plan
58,000
$25.94
$1.50M
David Malcom Rodman
15 Apr 2026
Chief Medical Officer
Sold on a plan
6,348
$27.66
$175.59K
Jon Congleton
13 Apr 2026
Chief Executive Officer
Sold on a plan
15,730
$26.83
$421.98K
Jon Congleton
31 Mar 2026
Chief Executive Officer
Sold on a plan
453
$27.05
$12.25K
Jon Congleton
31 Mar 2026
Chief Executive Officer
Sold on a plan
55,183
$26.54
$1.46M
Jon Congleton
31 Mar 2026
Chief Executive Officer
Sold on a plan
19,364
$25.50
$493.79K
David Malcom Rodman
14 Jan 2026
Chief Medical Officer
Sold on a plan
11,367
$32.61
$370.64K
Adam Scott Levy
12 Jan 2026
CFO and Secretary
Sold on a plan
10,758
$32.14
$345.72K
Jon Congleton
12 Jan 2026
Chief Executive Officer
Sold on a plan
7,117
$33.15
$235.93K
Jon Congleton
12 Jan 2026
Chief Executive Officer
Sold on a plan
9,119
$32.21
$293.71K
Show all 83 transactions →

What was left out

Form 4 filings counted 56
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 14
Sales straight out of an exercise 58
Sales at will 8
Transactions with no price 0
Shares from compensation/vesting 1,088,447
History held since 13 Feb 2023